09.04.25 -- STREAM Edition: Regulatory Guidance For Cleaning And Disinfecting

Explore how pharmaceutical companies can leverage innovative AI technologies while navigating the FDA’s evolving, risk-based regulatory approach to disruptive innovations.

Watch Tom Sellig, CEO of Adare, discuss the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

In this Pharmaceutical Online Live event, panelists discuss evolving regulatory guidance for cleaning, including revisions to PDA Technical Report 70 and USP 1072, and a new report on material transfer.

Uncover the strategic considerations for successfully navigating the regulatory complexities of targeted medicines, as well as learn about the challenges in translational medicine.

See how advanced x-ray inspection technology verifies correct pill count, identifies broken capsules, and detects foreign contaminants in pharmaceutical sachet packets.

Discover how a truly blind system eliminates bias from the human inspection process to improve data accuracy and validation of automated inspection systems.